Published in Antimicrob Agents Chemother on June 21, 2010
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. J Clin Microbiol (2013) 1.14
Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother (2012) 0.97
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist (2013) 0.95
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Virulence (2015) 0.80
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata. Antimicrob Agents Chemother (2015) 0.75
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol (2004) 4.03
Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect (2004) 3.26
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother (2008) 2.11
In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother (2002) 2.03
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother (2007) 1.55
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother (2008) 1.40
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol (2003) 1.11
Evaluation of Etest method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother (2008) 1.07
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis (2006) 0.97
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. J Antimicrob Chemother (2009) 0.96
Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol (2008) 0.88
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods]. Mikrobiyol Bul (2009) 0.81
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 11.12
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis (2007) 5.15
Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis (2005) 3.14
Nocardiosis at the turn of the century. Medicine (Baltimore) (2009) 2.55
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54
Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis (2005) 2.27
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother (2008) 2.11
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother (2003) 1.85
Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis (2005) 1.66
Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis (2013) 1.61
Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med (2007) 1.56
Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis (2003) 1.54
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med (2015) 1.54
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.50
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis (2008) 1.48
[Standards of care in pulmonary hypertension. Consensus statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC)]. Rev Esp Cardiol (2008) 1.46
Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol (2005) 1.45
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med (2009) 1.44
Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) (2007) 1.41
Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) (2010) 1.39
Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother (2004) 1.34
Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail (2005) 1.32
Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol (2006) 1.29
Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category. J Clin Microbiol (2011) 1.28
Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) (2008) 1.27
Advanced survey of tuberculosis transmission in a complex socioepidemiologic scenario with a high proportion of cases in immigrants. Clin Infect Dis (2008) 1.26
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J (2007) 1.26
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother (2013) 1.19
Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med (2009) 1.19
Evaluation of the new advanced 15-loci MIRU-VNTR genotyping tool in Mycobacterium tuberculosis molecular epidemiology studies. BMC Microbiol (2008) 1.19
Analysis of clonal composition of Mycobacterium tuberculosis isolates in primary infections in children. J Clin Microbiol (2004) 1.16
Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J Clin Microbiol (2009) 1.16
Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings. J Clin Microbiol (2005) 1.16
Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care (2009) 1.16
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med (2008) 1.16
Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report. BMC Cardiovasc Disord (2011) 1.15
Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? Crit Care (2012) 1.14
Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest (2006) 1.13
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One (2013) 1.13
The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture. Tuberculosis (Edinb) (2010) 1.13
Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med (2002) 1.12
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother (2006) 1.12
Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother (2004) 1.11
Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother (2005) 1.10
Extra-abdominal infections due to Gemella species. Int J Infect Dis (2002) 1.09
PCR for detection of herpes simplex virus in cerebrospinal fluid: alternative acceptance criteria for diagnostic workup. J Clin Microbiol (2013) 1.08
Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother (2013) 1.08
Mapping genetic diversity of cherimoya (Annona cherimola Mill.): application of spatial analysis for conservation and use of plant genetic resources. PLoS One (2012) 1.08
Rapid clonal analysis of recurrent tuberculosis by direct MIRU-VNTR typing on stored isolates. BMC Microbiol (2007) 1.07
Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection. J Infect Dis (2005) 1.06
Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet Microbiol (2009) 1.05
Prospective universal application of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping to characterize Mycobacterium tuberculosis isolates for fast identification of clustered and orphan cases. J Clin Microbiol (2009) 1.05
BK virus in heart transplant recipients: a prospective study. J Heart Lung Transplant (2010) 1.05
Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections. Future Microbiol (2008) 1.03
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era. Antimicrob Agents Chemother (2008) 1.03
Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved. J Clin Microbiol (2011) 1.02
Complex clonal features in an mycobacterium tuberculosis infection in a two-year-old child. Pediatr Infect Dis J (2006) 1.01
Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis. J Clin Microbiol (2011) 0.99
Bacteremia due to Roseomonas spp. Clin Microbiol Infect (1998) 0.99
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes. Antimicrob Agents Chemother (2007) 0.98
Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagn Microbiol Infect Dis (2011) 0.98
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother (2006) 0.98
Immunolocalisation of P2Y receptors in the rat eye. Purinergic Signal (2004) 0.97
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis (2006) 0.97
Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis. J Clin Microbiol (2006) 0.97
Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol (2012) 0.96
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Antimicrob Agents Chemother (2005) 0.96
Characterization of multiple isolates of Aspergillus fumigatus from patients: genotype, mating type and invasiveness. Med Mycol (2009) 0.96
Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol (2007) 0.96
Chlamydophila pneumoniae. Infect Dis Clin North Am (2010) 0.95
Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis (2003) 0.94
Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole. Diagn Microbiol Infect Dis (2002) 0.94
Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters. J Clin Microbiol (2011) 0.94
Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol (2008) 0.93
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Antimicrob Agents Chemother (2011) 0.93
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol (2008) 0.93
Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant (2007) 0.92
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain. Med Mycol (2010) 0.92